Jackson Financial Inc.

NYSE:JXN

Insurance - Life

Financial Services
$132.60 +0.61%

+$0.66 today

Market cap
$8.76B
Beta
1.33
P/E (TTM)
-20.4
EPS (TTM)
-$5.35
Dividend yield
3.12%
52W Low $82.30High $123.61

Volume 0.48M

Average 0.60M

JXN Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Jackson Financial Inc.NYSE: JXN

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development remains negative

Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMJun 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How JXN compares with its peers on the latest reported figures

  • JXN's LTM Jun 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for JXN, versus a peer median of 0.0%.
JXN Competitors Peer median
Research & Development for JXN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
JXNJackson Financial Inc.LTM Jun 2026$0 ——0.0%
METMetLife, Inc.LTM Jun 2026$0 ——0.0%
PRUPrudential Financial, Inc.LTM Jun 2026$0 ——0.0%
CRBGCorebridge Financial, Inc.LTM Jun 2026$0 ——0.0%
EQHEquitable Holdings, Inc.LTM Sep 2026$0 ——0.0%
VOYAVoya Financial, Inc.LTM Jun 2026$0 ——0.0%
LNCLincoln National CorporationLTM Jun 2026$0 ——0.0%
CNOCNO Financial Group, Inc.LTM Jun 2026$0 ——0.0%
FGF&G Annuities & Life, Inc.LTM Jun 2026$0 ——0.0%
BHFBrighthouse Financial, Inc.LTM Sep 2026$0 ——0.0%
Peer median (excluding JXN) $0——0.0%

Competitors are the stored peer set for JXN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.5B9.72B3.17B3.09B6.68B
Cost of Revenue511M812M698M702M971M
Gross Profit4.99B8.91B2.47B2.39B5.71B
Gross Margin90.7%91.6%77.9%77.3%85.5%
Research & Development00000
Selling, General & Admin1.08B875M1.01B1.12B0
Operating Expenses647M1.17B1.51B1.37B5.83B
Depreciation & Amortization11M0000
EBITDA4.39B7.83B1.07B1.12B(14M)
EBITDA Margin79.8%80.6%33.7%36.3%-0.2%
Operating Income4.35B7.73B958M1.02B(114M)
Operating Margin79.0%79.6%30.3%33.1%-1.7%
Interest Income00000
Interest Expense37M113M185M101M100M
Other Income / Expenses00000
Income Before Tax4.35B7.73B958M1.02B(114M)
Pre-Tax Margin79.0%79.6%30.3%33.1%-1.7%
Income Tax Expense666M1.51B4M46M(186M)
Net Income3.42B6.19B934M946M27M
Net Margin62.1%63.6%29.5%30.6%0.4%
EPS (Basic)35.8972.3410.7611.86(0.24)
EPS (Diluted)35.8969.7510.7611.74(0.24)
Weighted Avg Shares88.69M85.51M83.58M74.42M70.08M
Weighted Avg Shares (Diluted)88.69M88.69M83.58M74.42M70.28M

Jackson Financial Inc.

NYSE:JXN

Intrinsic Alpha fair value

Locked

Current Price

$132.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.